EPO and COVID-19: ,37, 38, 39 Accordingly, PTBP1 knockdown in primary CD34 cells treated with erythropoietin (EPO) resulted in the detection of OS/TS chimeras, which were also shown to have a significant correlation with asymptomatic disease status in COVID-19 patients.